Annals of urologic oncology (AUO, Ann Urol Oncol, p-ISSN: 2617-7765, e-ISSN: 2617-7773), publishes the results of novel research in the laboratory and clinical settings, including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human urologic oncology with the overall goal of improving clinical care of patients with urologic tumours. It includes three main subjects: bladder, prostate and kidney cancer. In addition, adrenal tumor, testicular cancer, and carcinoma of penis are also considered for the journal subjects.
Indexing Google Scholar, ResearchGate, DOAJ
Current Issue Volume 7 Issue 3, 2024 >>
Editorial board
Editors-in-Chief:
Renal cancer ranks as the 14th most common cancer globally, with renal cell carcinoma (RCC) being the primary variant, arising from renal tubular epit ...
Kirk Gallego
REVIEW | 17 Nov 2024
Bladder cancer is a complex disease with distinct treatment approaches based on its progression. For non-muscle invasive bladder cancer, the primary t ...
Clara Joseph
REVIEW | 13 Nov 2024
Prostate cancer (PCa) is a significant malignancy in men, contributing considerably to the rise in male mortality rates worldwide. Men diagnosed with ...
Nasser S Alanazi, Mohammed H Alrafiah
REVIEW | 26 Oct 2024
Prostate cancer (PCa) is a malignancy originating from the epithelial cells of the prostate gland, strongly influenced by androgens, and is one of the ...
Maham Khan
REVIEW | 18 Oct 2024
Extirpative bladder surgery for bladder cancer requires urinary diversion which causes cosmetic and functional changes that affect a patient’s body im ...
Ava Saidian, Hannah G Hingtgen ... Amirali Salmasi
RESEARCH | 13 Oct 2024
Prostate cancer (PCa) is the most common malignancy in the urinary system. Research suggest that prostate cancer is often accompanied by gene mutation ...
Xuguang Guo
REVIEW | 04 Aug 2024